Publication: 3418

Publication: 3418

Racial Differences in Survival and Response to Therapy in Patients with Metastatic Colorectal Cancer: A Secondary Analysis of CALGB/SWOG 80405 (Alliance A151931)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer vol 127 (20) 3801-3808

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 11

Parents:: None
Children:: None

Program:: CCP
Primary Committee:: Disparities
Sec. Committees:: GI

Pharmas:: Bristol-Myers Squibb, Genentech, Myriad, Pfizer, and Sanofi
Grants:: UG1 CA189823, U10 CA180821, U10 CA180882, UG1CA232760, UG1CA233327, UG1 CA233329, UG1 CA233331, UG1 CA233373, U10 CA180888, UG1 CA180830 (SWOG)

Corr. Author:
Authors:: Rebecca A. Snyder Jun He Jennifer Le-Rademacher Fang-Shu Ou Andrew B. Dodge Tyler J. Zemla Electra D. Paskett George J. Chang Federico Innocenti Charles Blanke Heinz-Josef Lenz Blase N. Polite Alan P. Venook

Networks:: CA011, CA824, LAPS-IL057, LAPS-MN026, LAPS-NC007, LAPS-OH007, LAPS-TX035, OR013

Study: Alliance-A151931
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80405
Phases:: N/A, 3

Keywords: